Bruck Kifle

Array ( [id] => 645731 [patent_doc_number] => 07119198 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-10 [patent_title] => 'Tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them' [patent_app_type] => utility [patent_app_number] => 11/182032 [patent_app_country] => US [patent_app_date] => 2005-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17174 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/119/07119198.pdf [firstpage_image] =>[orig_patent_app_number] => 11182032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5794264 [patent_doc_number] => 20060014945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Sulfonamides' [patent_app_type] => utility [patent_app_number] => 11/179703 [patent_app_country] => US [patent_app_date] => 2005-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29776 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014945.pdf [firstpage_image] =>[orig_patent_app_number] => 11179703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4922764 [patent_doc_number] => 20080071081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'Method for Catalytic Hydrogenation Purification of Lactam Containing Chlorolactam Impurities' [patent_app_type] => utility [patent_app_number] => 11/632339 [patent_app_country] => US [patent_app_date] => 2005-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3794 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20080071081.pdf [firstpage_image] =>[orig_patent_app_number] => 11632339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 663275 [patent_doc_number] => 07101870 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-05 [patent_title] => 'Succinoylamino lactams as inhibitors of A-β protein production' [patent_app_type] => utility [patent_app_number] => 11/175644 [patent_app_country] => US [patent_app_date] => 2005-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 72238 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/101/07101870.pdf [firstpage_image] =>[orig_patent_app_number] => 11175644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7070143 [patent_doc_number] => 20050245528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Reverse-turn mimetics and compositions and methods related thereto' [patent_app_type] => utility [patent_app_number] => 11/175920 [patent_app_country] => US [patent_app_date] => 2005-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13324 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20050245528.pdf [firstpage_image] =>[orig_patent_app_number] => 11175920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5063626 [patent_doc_number] => 20070225266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'Spiropiperidylrifamycins for the Treatment of Mycobacterial Infections' [patent_app_type] => utility [patent_app_number] => 11/572416 [patent_app_country] => US [patent_app_date] => 2005-07-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9617 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20070225266.pdf [firstpage_image] =>[orig_patent_app_number] => 11572416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 543151 [patent_doc_number] => 07169773 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-30 [patent_title] => 'Compounds' [patent_app_type] => utility [patent_app_number] => 11/171711 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14923 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/169/07169773.pdf [firstpage_image] =>[orig_patent_app_number] => 11171711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7046170 [patent_doc_number] => 20050250765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Diazepinones as antiviral agents' [patent_app_type] => utility [patent_app_number] => 11/165139 [patent_app_country] => US [patent_app_date] => 2005-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19699 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20050250765.pdf [firstpage_image] =>[orig_patent_app_number] => 11165139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7224808 [patent_doc_number] => 20050261287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Lactam-containing compounds and derivatives thereof as factor Xa inhibitors' [patent_app_type] => utility [patent_app_number] => 11/154972 [patent_app_country] => US [patent_app_date] => 2005-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 80434 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20050261287.pdf [firstpage_image] =>[orig_patent_app_number] => 11154972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6931762 [patent_doc_number] => 20050282797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Process for the preparation of oxcarbazepine and related intermediates' [patent_app_type] => utility [patent_app_number] => 11/153370 [patent_app_country] => US [patent_app_date] => 2005-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1931 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282797.pdf [firstpage_image] =>[orig_patent_app_number] => 11153370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7233453 [patent_doc_number] => 20050256098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'CGRP receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/152537 [patent_app_country] => US [patent_app_date] => 2005-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36836 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20050256098.pdf [firstpage_image] =>[orig_patent_app_number] => 11152537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5126450 [patent_doc_number] => 20070238721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'Highly Selective Novel Amidation Method' [patent_app_type] => utility [patent_app_number] => 11/628906 [patent_app_country] => US [patent_app_date] => 2005-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9360 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20070238721.pdf [firstpage_image] =>[orig_patent_app_number] => 11628906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7056458 [patent_doc_number] => 20050277633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-15 [patent_title] => 'Spiro-rifamycin derivatives targeting RNA polymerase' [patent_app_type] => utility [patent_app_number] => 11/147520 [patent_app_country] => US [patent_app_date] => 2005-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20800 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0277/20050277633.pdf [firstpage_image] =>[orig_patent_app_number] => 11147520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 754618 [patent_doc_number] => 07018998 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-28 [patent_title] => 'Glutamate receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/146693 [patent_app_country] => US [patent_app_date] => 2005-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41449 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/018/07018998.pdf [firstpage_image] =>[orig_patent_app_number] => 11146693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6493768 [patent_doc_number] => 20100093705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'Therapeutic agents, and methods of making and using the same' [patent_app_type] => utility [patent_app_number] => 11/628569 [patent_app_country] => US [patent_app_date] => 2005-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 78874 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093705.pdf [firstpage_image] =>[orig_patent_app_number] => 11628569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 742076 [patent_doc_number] => 07030245 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-18 [patent_title] => 'Antidepressant azahetorocyclylmethyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenathrene' [patent_app_type] => utility [patent_app_number] => 11/145727 [patent_app_country] => US [patent_app_date] => 2005-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8061 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/030/07030245.pdf [firstpage_image] =>[orig_patent_app_number] => 11145727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 369893 [patent_doc_number] => 07476666 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-13 [patent_title] => 'HIV integrase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/629153 [patent_app_country] => US [patent_app_date] => 2005-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38171 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/476/07476666.pdf [firstpage_image] =>[orig_patent_app_number] => 11629153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 33490 [patent_doc_number] => 07786105 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Pyrimidine compounds and use thereof' [patent_app_type] => utility [patent_app_number] => 11/628658 [patent_app_country] => US [patent_app_date] => 2005-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20703 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/786/07786105.pdf [firstpage_image] =>[orig_patent_app_number] => 11628658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 914562 [patent_doc_number] => 07326698 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-05 [patent_title] => 'Prostaglandin analogs' [patent_app_type] => utility [patent_app_number] => 10/549959 [patent_app_country] => US [patent_app_date] => 2005-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6253 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/326/07326698.pdf [firstpage_image] =>[orig_patent_app_number] => 10549959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 585830 [patent_doc_number] => 07442693 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-28 [patent_title] => 'Diazepine compounds as ligands of the melanocortin 1 and/or 4 receptors' [patent_app_type] => utility [patent_app_number] => 11/569257 [patent_app_country] => US [patent_app_date] => 2005-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20318 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/442/07442693.pdf [firstpage_image] =>[orig_patent_app_number] => 11569257 [rel_patent_id] =>[rel_patent_doc_number] =>)